Itamar Har-Even on CNBC: Econ Downturn Will Hit Ride-Sharing Firms
Ride-sharing is one of ‘hardest hit’ sectors amid virus crisis, says investor “Whether or not people can muster the political support to save some of these companies which have never been profitable … will be kind of a tough sell on a governmental level,” says Itamar Har-Even, Ion Pacific’s co-founder and co-CEO on the challenges […]
Michael Joseph on Deal Street Asia – Coronavirus: Liquidity will come at a premium for VC asset class
While the final human toll of coronavirus is still to be determined, one thing is for certain: COVID-19 is leaving a deep mark on our economy and creating an abundance of fear. The Dow, S&P 500 had the worst March since the Great Depression, as investors are assessing the pandemic’s impact on the slowing American […]
Michael Joseph spoke about Asia’s largest companies try to sell down stakes in start-ups with Financial Times
Asia’s largest companies try to sell down stakes in start-ups _ Financial Times Corporate venture capital funds offer Gojek and Didi Chuxing to secondary market investors Asia’s biggest companies are selling down their stakes in the region’s most promising tech start-ups, including Indonesia’s Gojek and China’s Didi Chuxing, as they refocus their resources to weather […]
Market Insider: Ion Pacific Co-Founder Michael Joseph to Lead Israel Operations
Appointment highlights Israel’s importance to Ion Pacific’s strategy Ion Pacific to ramp up its engagement with Tel Aviv’s tech ecosystem HONG KONG, March 25, 2020 (GLOBE NEWSWIRE) — Ion Pacific today announced that founding partner Michael Joseph will take over as Head of Operations for Israel. This appointment of Michael Joseph highlights Israel’s importance to […]
Michael Joseph appears on Asset Finance International to share his view on Funding innovation while minimising risk
The allure of venture capital is undeniable – the hope everlasting of finding a unicorn that goes on to a jackpot IPO fueled venture capital assets under management to swell to $940 billion by Q2 last year. And yet many investors are also acutely aware of the risks of investing in venture capital; committing money […]
Itamar Har-Even interviewed by Bloomberg radio explains potentials on AI for medical diagnosis
Itamar Har-Even, Co-CEO/Managing Director/Co-Founder, Ion Pacific, joined Rishaad Salamat and Doug Krizner on Daybreak Asia. He discusses some of the key trends he is seeing within private markets and why investors should still be careful over blockchain technology. He goes on to say AI for medical diagnosis is a fascinating sector. Listen the full interview […]
Itamar Har-Even Interviewed by CNBC on Alibaba’s secondary listing
Itamar Har-Even of Ion Pacific says Alibaba’s secondary listing is an example of China finding ways to bring its national champions back to Hong Kong, which he says has done “very well” in terms of the number of IPOs launched in 2019. He also says Megvii is very likely to list in Hong Kong in […]
Michael Joseph commented on VC partnerships
VC partnerships: Mind games In private equity, cross-cultural miscommunication and sheer bravado are the most commonly cited reasons for personal friction derailing what might have been a fruitful relationship. But in venture capital, some of the biggest psychological pitfalls stem from a lack of familiarity with the asset class itself. Michael Joseph, a managing director […]
Itamar Har-Even Interviewed by Bloomberg Radio on the outlook for tech IPOs in 2020
Itamar Har-Even, Co-Founder and CEO, Ion Pacific, joined Bryan Curtis and Juliette Saly on Daybreak Asia. He discusses the outlook for tech IPOs in 2020, taking a look at what companies need to demonstrate to potential investors. Listen to the full interview here.
Itamar Har-Even Interviewed by CNBC on tech IPO valuation
Itamar Har-Even of Ion Pacific says technology initial public offerings will slow down before coming back again, but valuations will need to be much more reasonable. He also says companies may not get the valuations they want, but will have to be patient. Watch the full interview here.
